Tricuspid Regurgitation: Disease State and Advances in Percutaneous Therapy
Tricuspid regurgitation (TR) is a relatively common finding. There has been growing recognition of the morbidity and adverse prognosis of severe TR, which affects 1.6 million people in the US. However, symptomatic TR remains undertreated despite emerging therapeutic modalities. In this review, the p...
Saved in:
Main Authors: | Qiuyu Martin Zhu, Natalia Berry |
---|---|
Format: | Article |
Language: | English |
Published: |
Radcliffe Medical Media
2023-09-01
|
Series: | European Cardiology Review |
Online Access: | https://www.ecrjournal.com/articleindex/ecr.2023.09 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Evolving Role of Transcatheter Tricuspid Valve Edge-to-Edge Repair in Tricuspid Regurgitation
by: Peng Zhang, et al.
Published: (2024-03-01) -
Natural course of tricuspid regurgitation and prognostic implications
by: Peter Bramlage, et al.
Published: (2021-02-01) -
Transcatheter Edge-to-edge Repair of Severe Tricuspid Regurgitation
by: Shu-I Lin, et al.
Published: (2019-01-01) -
Diagnostic Management and Surgical Treatment of Isolated Tricuspid Regurgitation
by: Arthur Cicupira Rodrigues de Assis, et al.
Published: (2021-01-01) -
Tricuspid Regurgitation in the Setting of Cardiac Implantable Electronic Devices
by: Omar M. Aldaas, MD, et al.
Published: (2025-01-01)